A phase II study of biweekly paclitaxel (P) and gemcitabine (G), followed by maintenance weekly paclitaxel in elderly patients with advanced non-small cell lung cancer (NSCLC)
- Resource Type
- Article
- Source
- In
Lung Cancer 2008 60(3):381-386 - Subject
- Language
- ISSN
- 0169-5002